Bulk Pharmaceuticals - Group A (Materiel)

THIS AMENDMENT IS ISSUED TO REVISE THE SOLICITED QUANTITIES AND REVISE STATEMENT OF WORK SECTION D.3.3 - RETURNS & RECALLS. QUANTITIES ARE REVISED IN RFP ATTACHMENT 1 AND RFP ATTACHMENT 2. 

THE CLOSING DATE OF THE SOLICITATION IS EXTENDED TO APRIL 3, 2025, AT 11:00 A.M. (EST).

*********************************************************************************

THIS AMENDMENT IS ISSUED TO PUBLISH ANSWERS TO VENDOR QUESTIONS.  PLEASE SEE ATTACHED "ANSWERS TO VENDOR QUESTIONS."

***************************************************

This is a combined synopsis/solicitation for commercial supplies in accordance with FAR Part 12. This announcement constitutes the only solicitation; proposals are being requested and a written .... Read More

This is a combined synopsis/solicitation for commercial supplies in accordance with FAR Part 12. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. This synopsis/solicitation is issued on the basis of full and open competition and is not set aside for small businesses.  The NAICS code is 325412 (Pharmaceutical Preparation Manufacturing).  The size standard is 1,300 (number of employees).

The Center for the Strategic National Stockpile (SNS) has a need to procure a variety of FDA-approved pharmaceuticals to maintain minimum stockpiling capabilities for responding to public health events. The .... Read More